There are 2867 resources available
Introduction and scientific background
Presenter: Sarah-Jane Dawson
Session: Detection, characterisation and targeting of minimal residual disease
Resources:
Slides
Webcast
LBA24 - KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation
Presenter: Samuel Klempner
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Abstract
Slides
Webcast
Personalizing first-line immunotherapy: Beyond one size fits all
Presenter: Luis Paz-Ares
Session: The current and future of immunotherapy for metastatic NSCLC
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Florian Lordick
Session: Evolving targets and treatment options in oesophagogastric cancer
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Brigette Ma
Session: New developments in the management of recurrent/metastatic nasopharyngeal cancer
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Marianne Pavel
Session: Personalized oncology in thyroid cancers: Moving from multi-targeted agents to tumor agnostic indications?
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Debbie Robbrecht
Session: Multidisciplinary updates in biomarkers in urinary cancers
Resources:
Slides
Webcast
788O - Association of pre-treatment ctDNA with disease recurrence and clinical and translational factors in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy (CheckMate 915)
Presenter: Georgina Long
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
315O - Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort
Presenter: Yasutoshi Kuboki
Session: Proffered Paper session 2: GI, lower digestive
Resources:
Abstract
Slides
Webcast
Small cell lung cancer: How molecular insights have shed light on aggressive clinical behaviour
Presenter: Charles Rudin
Session: Hard-to-treat cancers: What makes them special?
Resources:
Slides
Webcast